1. Pasteris, N G, Gorski, J L. . Isolation, characterization, and mapping of the mouse and human Fgd2 genes, faciogenital dysplasia (FGD1; Aarskog syndrome) gene homologues. In Genomics, 60, 57-66. doi:. https://pubmed.ncbi.nlm.nih.gov/10458911/
2. Génin, Emmanuelle, Huebner, Angela, Jaillard, Christine, Bégeot, Martine, Naville, Danielle. 2002. Linkage of one gene for familial glucocorticoid deficiency type 2 (FGD2) to chromosome 8q and further evidence of heterogeneity. In Human genetics, 111, 428-34. doi:. https://pubmed.ncbi.nlm.nih.gov/12384787/
3. Huber, Christoph, Mårtensson, Annica, Bokoch, Gary M, Nemazee, David, Gavin, Amanda L. 2008. FGD2, a CDC42-specific exchange factor expressed by antigen-presenting cells, localizes to early endosomes and active membrane ruffles. In The Journal of biological chemistry, 283, 34002-12. doi:10.1074/jbc.M803957200. https://pubmed.ncbi.nlm.nih.gov/18838382/
4. Ning, Xuchao, Li, Renzhi, Zhang, Bin, Lyu, Xiajie, Chen, Zhenyu. 2021. Immune Score Indicator for the Survival of Melanoma Patients Based on Tumor Microenvironment. In International journal of general medicine, 14, 10397-10416. doi:10.2147/IJGM.S336105. https://pubmed.ncbi.nlm.nih.gov/35002296/
5. Ma, Chao, Li, Haoyu, Li, Xian, Lu, Shuwen, He, Jianfeng. 2019. The prognostic value of faciogenital dysplasias as biomarkers in head and neck squamous cell carcinoma. In Biomarkers in medicine, 13, 1399-1415. doi:10.2217/bmm-2019-0273. https://pubmed.ncbi.nlm.nih.gov/31596126/